TVTX
#1301
Travere Therapeutics, Inc. - Common Stock
56.2 9 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.53%
Monthly Change
+6.63%
6 month change
+96.34%
Year Change
+95.66%
Previous Close
56.5 9
Open
56.2 9
Low
56.2 9
High
56.2 9
Volume
190
Financials
- Market Capitalization 5.23 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-135.05
Price to sales ratio
5.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1267 |  ERAS Erasca, Inc. - Common Stock | 17.90 USD | -3.40% | -5.14% | +27.22% | +1126.03% | 5.57 B USD | ||
| 1282 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 98.64 USD | +1.07% | +5.68% | +18.29% | +388.56% | 5.39 B USD | ||
| 1329 |  CELC Celcuity Inc. - Common Stock | 103.79 USD | -3.52% | -6.02% | +15.36% | +649.39% | 5.06 B USD | ||
| 1360 |  CRSP CRISPR Therapeutics AG - Common Shares | 50.63 USD | -5.10% | -18.52% | -0.73% | -10.23% | 4.88 B USD |
Frequently asked questions about Travere Therapeutics, Inc. - Common Stock
What is the Travere Therapeutics, Inc. - Common Stock stock price today?
The current price of Travere Therapeutics, Inc. - Common Stock (TVTX) is 56.29. Over the past 24 hours, the stock has changed by -0.53%. Follow the TVTX chart for real-time price dynamics.
What is the stock ticker of Travere Therapeutics, Inc. - Common Stock?
Travere Therapeutics, Inc. - Common Stock trades under the ticker TVTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Travere Therapeutics, Inc. - Common Stock stock going up?
TVTX has changed by -2.58% over the last week, +6.63% over the last month, and +95.66% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Travere Therapeutics, Inc. - Common Stock net income for the last quarter?
Travere Therapeutics, Inc. - Common Stock reported net income of -37.1 M for the last quarter. The previous quarter showed 2.73 M, which means net income changed by -1459.55%.
How many employees does Travere Therapeutics, Inc. - Common Stock have?
As of the latest available data, Travere Therapeutics, Inc. - Common Stock has 497 employees. Workforce size can provide additional context about the company's scale and operations.
What is Travere Therapeutics, Inc. - Common Stock EBITDA?
Travere Therapeutics, Inc. - Common Stock EBITDA is -11.7 M, and its EBITDA margin is -9.2%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Travere Therapeutics, Inc. - Common Stock stock?
You can buy Travere Therapeutics, Inc. - Common Stock (TVTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Travere Therapeutics, Inc. - Common Stock stock?
Investing in Travere Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TVTX chart and related analysis on metatrader.com as part of your research.